The Patient's Bill of Rights: a significant aspect of the consumer revolution.
Explore the source record for details and available documents.
Consumer Behavior↗
Biomedical subjects
N Quinn
Publications and source records attributed to N Quinn.
Disorders of the basal ganglia and their modern management.
Explore the source record for details and available documents.
Antiparkinson Agents↗
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm].
The response to different therapeutic methods was evaluated in a series of 264 patients with blepharospasm. The most effective drug therapy were anticholinergic agents, which resulted in the initial improvement of symptoms in 20% of treated patients. There was improvement in isolated cases treated with levodopa, dopaminergic agonists, neuroleptics, benzodiazepines and tricyclic antidepressants. Bilateral avulsion of the facial nerve was carried out in 29 patients; 27 of these (93%) improved. Spasms relapsed in 22 cases, after a mean period of 12 months. Myectomy of the orbicular muscle was performed in 8 patients. In only 2 cases some improvement was obtained. One hundred and fifty-one patients were treated with infiltrations of botulinum toxin A in the orbicular muscle. 78% of cases improved. The mean duration of the benefit of each injection was 9.2 weeks. The most common secondary effects were local (ptosis, diplopia) and transient.
Blepharospasm↗
Multiple system atrophy.
Most doctors have vague and imprecise notions of what is meant by the terms olivopontocerebellar atrophy, Shy-Drager syndrome, striatonigral degeneration, multiple system atrophy and multisystem degenerations. This article attempts to tame this nosological jungle.
Atrophy↗